ArticleFrontiers in oncology2022

MARCH1 as a novel immune-related prognostic biomarker that shapes an inflamed tumor microenvironment in lung adenocarcinoma.

Zhiyong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.